Xencor
Utility Patent Applications
Last updated:
List of all Xencor patents 74 in total
| Status | Patent |
|---|---|
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND PSMA Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38 Filling date: 8 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: METHODS OF TREATING NEUROLOGICAL DISEASES Filling date: 8 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN Filling date: 8 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMBINATION THERAPIES THEREOF Filling date: 8 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR SIMULTANEOUS BIVALENT AND MONOVALENT CO-ENGAGEMENT OF ANTIGENS Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: HETERODIMERIC PROTEINS Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES Filling date: 8 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: PD-1 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15Ra Fc-FUSION PROTEINS AND PD-1 ANTIGEN BINDING DOMAINS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: IL-15/IL-15RA HETERODIMERIC FC FUSION PROTEINS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINS Filling date: 8 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: TRISPECIFIC ANTIBODIES Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: OPTIMIZED ANTIBODY VARIABLE REGIONS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES Filling date: 8 Sep 2025 Issue date: 29 Aug 2019 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND SOMATOSTATIN RECEPTOR 2 Filling date: 8 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: ENGINEERED IL-2 Fc FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Showing 50 to 74 of 74 patents.